Strategies to increase the sensitivity of pharmacovigilance in Portugal;Estratégias para aumentar a sensibilidade da farmacovigilância em Portugal

Revista de Saude Publica

Volumn 45, Issue 1, 2011, Pages 129-135

  Ribeiro Vaz, Inês ^a   Herdeiro, Maria Teresa ^b   Polónia, Jorge ^a   Figueiras, Adolfo ^c  

^a University of Porto   (Portugal)

^b Polytechnic Health Institute of North   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adverse drug reaction reporting systems; Adverse effects; Drug toxicity; Health education; Health surveillance; Intervention studies; Pharmaceutical preparations; Prevention control

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; EDUCATION; FEMALE; HUMAN; MALE; METHODOLOGY; PHARMACIST; PORTUGAL; POSTMARKETING SURVEILLANCE; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; EDUCATION, PHARMACY, CONTINUING; FEMALE; HUMANS; MALE; PHARMACISTS; PORTUGAL; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 78650478678     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-89102011000100011     Document Type: Article

References (19)

1. Castel J, Figueras A, Pedrós C, Laporte J, Capellà D. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf. 2003;26(14):1049-55. DOI:10.2165/00002018-200326140-00005.
2. Davis D, Thomson M, Oxman A, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274(9):700-5.
3. Einarson TR. Drug-related hospital admissions. Ann Pharmacother. 1993;27(7-8):832-40.
4. Figueiras A, Herdeiro M, Polónia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086-93.
5. Gunderman RB, Phillips MD, Cohen MD. Improving clinical histories on radiology requisitions. Acad Radiol. 2001;8(4):299-303. DOI:10.1016/S1076-6332(03)80498-1.
6. Heo M, Leon AC. Comparison of statistical methods for analysis of clustered binary observations. Stat Med. 2005;24(6):911-23. DOI:10.1002/sim.1958.
7. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825-33. DOI:10.2165/00002018-200528090-00007.
8. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331-40. DOI:10.2165/00002018-200629040-00004.
9. Herdeiro MT, Polónia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31(4):335-44. DOI:10.2165/00002018-200831040-00007.
10. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670-4.
11. Inman W. Assessment drug safety problems. In: Gent MSI, editor. Epidemiological issues in reported drug-induced illnesses. Honolulu: McMaster University Library Press; 1976. p.17-24.
12. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17):2215-20.
13. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-5.
14. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997;44(1):98-100. DOI:10.1046/j.1365-2125.1997.00616.x.
15. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9.
16. Richards D, Toop L, Graham P. Do clinical practice education groups result in sustained change in GP prescribing? Fam Pract. 2003;20(2):199-206. DOI:10.1093/fampra/20.2.199.
17. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJM, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42(4):423-9. DOI:10.1111/j.1365-2125.1996.tb00004.x.
18. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000(2):CD000409.
19. Torgerson DJ, Campbell MK. Economics notes: cost effectiveness calculations and sample size. BMJ. 2000;321(7262):697.